KK
RYTM icon

KLP Kapitalforvaltning’s Rhythm Pharmaceuticals RYTM Stock Holding History

KLP Kapitalforvaltning’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Hold
12,500
– – ﹤0.01% 958
2026
Q1 		$1.09M Buy
12,500
+500
+4% +$48.6K ﹤0.01% 985
2025
Q4 		$1.28M Buy
12,000
+1,000
+9% +$106K 0.01% 898
2025
Q3 		$1.11M Buy
11,000
+800
+8% +$74.3K ﹤0.01% 969
2025
Q2 		$645K Buy
10,200
+900
+10% +$55.1K ﹤0.01% 1220
2025
Q1 		$493K Hold
9,300
– – ﹤0.01% 1307
2024
Q4 		$521K Buy
+9,300
New +$514K ﹤0.01% 1356

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

KLP Kapitalforvaltning's RYTM Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Rhythm Pharmaceuticals (RYTM) position steady in Q2 2026 at 12,500 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #958.

KLP Kapitalforvaltning first reported a position in RYTM in Q4 2024 and has held it in 7 quarters since. 303 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • KLP Kapitalforvaltning held 12,500 shares of Rhythm Pharmaceuticals worth $1.39M as of Q2 2026.
  • KLP Kapitalforvaltning left its Rhythm Pharmaceuticals share count unchanged in Q2 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #958 holding.
  • KLP Kapitalforvaltning first reported a position in Rhythm Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 303 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.